Literature DB >> 10676919

The spleen: anatomy and anatomical function.

A Chadburn1.   

Abstract

In this review, our knowledge concerning the structure and function of the spleen is summarized. The unique architecture of the spleen allows for interactions between the circulatory, reticuloendothelial, and immune systems. Based on these interactions in conjunction with its microanatomy, the spleen is able to maintain the integrity of the blood and respond to circulating antigens. However, this can be a double-edged sword in the case of patients suffering from autoimmune diseases such as immune thrombocytopenic purpura since the spleen can be the site of both antibody production and circulating cell destruction.

Entities:  

Mesh：

Year:  2000        PMID： 10676919     DOI： 10.1016/s0037-1963(00)90113-6

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


  17 in total

1.  Splenic hemangiomatosis.

Authors:  Thomas H Louis; James M Sanders; Jill S Stephenson; Lori N Harbour; Kenneth L Ford
Journal:  Proc (Bayl Univ Med Cent)       Date:  2011-10

2.  Immune profile of asplenic patients following single or double vaccine administration: A longitudinal cross-sectional study.

Authors:  Sait Murat Doğan; Ahmet Aykas; Evrim Şefika Yücel; Gökalp Okut; Cenk Şimşek; Kürşat Çayhan; Baha Zengel; Adam Uslu
Journal:  Ulus Cerrahi Derg       Date:  2015-04-09

3.  The characteristics of vessel lining cells in normal spleens and their role in the pathobiology of myelofibrosis.

Authors:  Jiajing Qiu; Mohamed E Salama; Cing Siang Hu; Yan Li; Xiaoli Wang; Ronald Hoffman
Journal:  Blood Adv       Date:  2018-05-22

4.  Penicillar arterioles of red pulp in residual spleen after subtotal splenectomy due to splenomegaly in cirrhotic patients: a comparative study.

Authors:  Xiaoji Zhu; Wei Han; Lei Wang; Haibo Chu; Jianhua Zhao; Yongbo Xu; Tao Wang; Wenjun Guo
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

Review 5.  Stem cells in the spleen: therapeutic potential for Sjogren's syndrome, type I diabetes, and other disorders.

Authors:  Denise L Faustman; Miriam Davis
Journal:  Int J Biochem Cell Biol       Date:  2010-06-18       Impact factor: 5.085

6.  Nanoparticles camouflaged in platelet membrane coating as an antibody decoy for the treatment of immune thrombocytopenia.

Authors:  Xiaoli Wei; Jie Gao; Ronnie H Fang; Brian T Luk; Ashley V Kroll; Diana Dehaini; Jiarong Zhou; Hyeon Woo Kim; Weiwei Gao; Weiyue Lu; Liangfang Zhang
Journal:  Biomaterials       Date:  2016-10-05       Impact factor: 12.479

7.  Null Function of Npr1 Disturbs Immune Response in Colonic Inflammation During Early Postnatal Stage.

Authors:  Changkun Long; Hongfei Liu; Wenxing Zhan; Liping Chen; Andong Wu; Lin Yang; Shenghan Chen
Journal:  Inflammation       Date:  2022-07-07       Impact factor: 4.092

Review 8.  Modern management of splenomegaly in patients with myelofibrosis.

Authors:  Douglas Tremblay; Myron Schwartz; Richard Bakst; Rahul Patel; Thomas Schiano; Marina Kremyanskaya; Ronald Hoffman; John Mascarenhas
Journal:  Ann Hematol       Date:  2020-05-17       Impact factor: 3.673

Review 9.  Splenic Artery Embolization for Patients with High-Grade Splenic Trauma: Indications, Techniques, and Clinical Outcomes.

Authors:  Majd Habash; Darrel Ceballos; Andrew J Gunn
Journal:  Semin Intervent Radiol       Date:  2021-04-15       Impact factor: 1.513

10.  Mechanism of hard-nanomaterial clearance by the liver.

Authors:  Kim M Tsoi; Sonya A MacParland; Xue-Zhong Ma; Vinzent N Spetzler; Juan Echeverri; Ben Ouyang; Saleh M Fadel; Edward A Sykes; Nicolas Goldaracena; Johann M Kaths; John B Conneely; Benjamin A Alman; Markus Selzner; Mario A Ostrowski; Oyedele A Adeyi; Anton Zilman; Ian D McGilvray; Warren C W Chan
Journal:  Nat Mater       Date:  2016-08-15       Impact factor: 43.841
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.